How real-world data is powering rare disease research Part 2. RWD advances in Europe
As real-world data (RWD) transforms the drug development landscape, its power to advance research is becoming tangible in the most challenging therapeutic arena—rare diseases. In this series, Parexel experts discuss current initiatives in North America, Europe and China that are accelerating the use of RWD in rare disease research.
Related Insights
Whitepaper
How real-world data is powering rare disease research Part 3. RWD advances in China
Apr 18, 2025
Webinar
Adaptive strategies for more efficient, data-rich and patient-friendly trials
May 28, 2023
Article
PharmaVOICE - The RWE Evolution
Apr 13, 2021
Article
Guide for Real-World Evidence
May 21, 2021
Article
Lessons from China and the United States on the use of RWE in regulatory submissions
Jul 19, 2021
Article
New FDA Guidance Addresses the Need for Data-Generation Strategies Across the Drug Development Lifecycle
May 10, 2022
Blog
Maintaining Data Integrity for Quality and Compliance – Essential Despite Pandemic Disruptions
May 16, 2022
Playbook
Are you using real-world evidence?
Feb 1, 2023
Video
The science and practice of ethnobridging
May 17, 2023
Webinar
Assessing appropriate use of ECAs in clinical trials
May 28, 2023
Whitepaper
How real-world data is powering rare disease research Part 1. RWD advances in North America
Apr 18, 2025
Blog
A hybrid model supports globally diverse site participation for a retrospective cancer study
Jul 24, 2023
Related Insights
Whitepaper
How real-world data is powering rare disease research Part 3. RWD advances in China
Apr 18, 2025
Webinar
Adaptive strategies for more efficient, data-rich and patient-friendly trials
May 28, 2023
Article
PharmaVOICE - The RWE Evolution
Apr 13, 2021
Article
Guide for Real-World Evidence
May 21, 2021
Article
Lessons from China and the United States on the use of RWE in regulatory submissions
Jul 19, 2021
Article
New FDA Guidance Addresses the Need for Data-Generation Strategies Across the Drug Development Lifecycle
May 10, 2022
Blog
Maintaining Data Integrity for Quality and Compliance – Essential Despite Pandemic Disruptions
May 16, 2022
Playbook
Are you using real-world evidence?
Feb 1, 2023
Video
The science and practice of ethnobridging
May 17, 2023
Webinar
Assessing appropriate use of ECAs in clinical trials
May 28, 2023
Whitepaper
How real-world data is powering rare disease research Part 1. RWD advances in North America
Apr 18, 2025
Blog
A hybrid model supports globally diverse site participation for a retrospective cancer study
Jul 24, 2023